Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Ankle-brachial index and bone turnover in patients on dialysis.

London GM, Marchais SJ, Guérin AP, de Vernejoul MC.

J Am Soc Nephrol. 2015 Feb;26(2):476-83. doi: 10.1681/ASN.2014020169. Epub 2014 Sep 17.

2.

Vascular calcifications, arterial aging and arterial remodeling in ESRD.

London GM, Pannier B, Marchais SJ.

Blood Purif. 2013;35(1-3):16-21. doi: 10.1159/000345172. Epub 2013 Jan 22.

3.

Central artery pulse pressure in end-stage renal disease: the roles of aortic diameter, aortic stiffness and wave reflection.

Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM.

Blood Purif. 2011;31(1-3):107-12. doi: 10.1159/000322104. Epub 2011 Jan 10.

4.

Assessment and significance of arterial stiffness in patients with chronic kidney disease.

Guérin AP, Pannier B, Métivier F, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):635-41. Review.

PMID:
19031658
5.

Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC.

J Am Soc Nephrol. 2008 Sep;19(9):1827-35. doi: 10.1681/ASN.2007050622. Epub 2008 May 14.

6.

Arterial structure and function in end-stage renal disease.

Guérin AP, Pannier B, Marchais SJ, London GM.

Curr Hypertens Rep. 2008 Apr;10(2):107-11. Review.

PMID:
18474176
7.

Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.

London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F.

J Am Soc Nephrol. 2007 Feb;18(2):613-20. Epub 2007 Jan 3.

8.

Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.

Guérin AP, Pannier B, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2006 Mar;15(2):105-10. Review.

PMID:
16481874
9.

Arterial structural and functional alterations in uraemia.

Guérin AP, Marchais SJ, Metivier F, London GM.

Eur J Clin Invest. 2005 Dec;35 Suppl 3:85-8. Review.

PMID:
16281963
10.

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.

London GM, Marchais SJ, Guérin AP, Métivier F.

Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31. Review.

PMID:
16205470
11.

Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.

Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM.

Hypertension. 2005 Apr;45(4):592-6. Epub 2005 Mar 7.

PMID:
15753232
12.

Arterial stiffness: pathophysiology and clinical impact.

London GM, Marchais SJ, Guerin AP, Pannier B.

Clin Exp Hypertens. 2004 Oct-Nov;26(7-8):689-99. Review.

PMID:
15702623
13.

Cardiovascular disease in renal failure.

Guerin AP, Adda H, London GM, Marchais SJ.

Minerva Urol Nefrol. 2004 Sep;56(3):279-88. Review.

14.

Arterial stiffness and function in end-stage renal disease.

London GM, Marchais SJ, Guerin AP.

Adv Chronic Kidney Dis. 2004 Apr;11(2):202-9. Review.

PMID:
15216492
15.

Arterial calcifications and bone histomorphometry in end-stage renal disease.

London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC.

J Am Soc Nephrol. 2004 Jul;15(7):1943-51.

16.

Forearm reactive hyperemia and mortality in end-stage renal disease.

London GM, Pannier B, Agharazii M, Guerin AP, Verbeke FH, Marchais SJ.

Kidney Int. 2004 Feb;65(2):700-4.

17.

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H.

Nephrol Dial Transplant. 2003 Sep;18(9):1731-40.

PMID:
12937218
18.

Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients.

London GM, Marchais SJ, Guerin AP, Metivier F, Adda H, Pannier B.

Kidney Int Suppl. 2003 May;(84):S88-93.

PMID:
12694318
19.

Aortic pulse wave velocity index and mortality in end-stage renal disease.

Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ, London GM.

Kidney Int. 2003 May;63(5):1852-60.

20.

Prognostic significance of arterial stiffness measurements in end-stage renal disease patients.

Blacher J, Safar ME, Pannier B, Guerin AP, Marchais SJ, London GM.

Curr Opin Nephrol Hypertens. 2002 Nov;11(6):629-34. Review.

PMID:
12394609
21.

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Drüeke T, Witko-Sarsat V, Massy Z, Descamps-Latscha B, Guerin AP, Marchais SJ, Gausson V, London GM.

Circulation. 2002 Oct 22;106(17):2212-7.

PMID:
12390950
22.

Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach.

London GM, Marchais SJ, Guérin AP, Métivier F.

Nephrol Dial Transplant. 2002;17 Suppl 11:13-5. Review.

PMID:
12386250
23.

Arterial structure and function in end-stage renal disease.

London GM, Marchais SJ, Guerin AP, Metivier F, Adda H.

Nephrol Dial Transplant. 2002 Oct;17(10):1713-24. No abstract available.

PMID:
12270974
24.

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.

Pannier BM, Guerin AP, Marchais SJ, London GM.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1074-7.

PMID:
11903319
25.

Central pulse pressure and mortality in end-stage renal disease.

Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM.

Hypertension. 2002 Mar 1;39(3):735-8.

PMID:
11897754
26.

Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, Metivier F, Adda H, Safar ME.

J Am Soc Nephrol. 2001 Dec;12(12):2759-67.

27.

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM.

Hypertension. 2001 Oct;38(4):938-42.

PMID:
11641313
28.

Arterial wave reflections and survival in end-stage renal failure.

London GM, Blacher J, Pannier B, Guérin AP, Marchais SJ, Safar ME.

Hypertension. 2001 Sep;38(3):434-8.

PMID:
11566918
29.

Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM.

Circulation. 2001 Feb 20;103(7):987-92.

PMID:
11181474
30.

Cardiovascular risk in end-stage renal disease: vascular aspects.

London GM, Marchais SJ, Metivier F, Guerin AP.

Nephrol Dial Transplant. 2000;15 Suppl 5:97-104. Review. No abstract available.

PMID:
11073281
31.

Pathophysiology of anaemia: focus on the heart and blood vessels.

Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM.

Nephrol Dial Transplant. 2000;15 Suppl 3:14-8. Review.

PMID:
11032352
32.

Pathophysiology of cardiovascular disease in hemodialysis patients.

Meeus F, Kourilsky O, Guerin AP, Gaudry C, Marchais SJ, London GM.

Kidney Int Suppl. 2000 Aug;76:S140-7. Review.

PMID:
10936811
33.

Arterial stiffening and vascular calcifications in end-stage renal disease.

Guérin AP, London GM, Marchais SJ, Metivier F.

Nephrol Dial Transplant. 2000 Jul;15(7):1014-21.

PMID:
10862640
34.

Calcification of the aortic valve in the dialyzed patient.

London GM, Pannier B, Marchais SJ, Guerin AP.

J Am Soc Nephrol. 2000 Apr;11(4):778-83. Review. No abstract available.

35.

Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.

Pannier B, Guerin AP, Marchais SJ, Metivier F, Safar ME, London GM.

Kidney Int. 2000 Mar;57(3):1091-9.

36.

Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease.

Marchais SJ, Metivier F, Guerin AP, London GM.

Nephrol Dial Transplant. 1999 Sep;14(9):2178-83.

PMID:
10489228
37.

Impact of aortic stiffness on survival in end-stage renal disease.

Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM.

Circulation. 1999 May 11;99(18):2434-9.

PMID:
10318666
38.

Large artery structure and function in hypertension and end-stage renal disease.

London GM, Guerin AP, Pannier B, Marchais SJ, Safar ME.

J Hypertens. 1998 Dec;16(12 Pt 2):1931-8. Review.

PMID:
9886879
39.

Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease.

Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM.

Hypertension. 1998 Sep;32(3):570-4.

PMID:
9740628
40.

Influence of body height on pulsatile arterial hemodynamic data.

Smulyan H, Marchais SJ, Pannier B, Guerin AP, Safar ME, London GM.

J Am Coll Cardiol. 1998 Apr;31(5):1103-9.

41.

Arterial remodeling and cardiovascular function in end-stage renal disease.

Guérin AP, Pannier B, Marchais SJ, Metivier F, London GM.

Adv Nephrol Necker Hosp. 1997;27:105-29. Review. No abstract available.

PMID:
9408445
42.

Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.

London GM, Pannier B, Vicaut E, Guérin AP, Marchais SJ, Safar ME, Cuche JL.

J Hypertens. 1996 Sep;14(9):1139-46.

PMID:
8986916
43.

Cardiac and arterial interactions in end-stage renal disease.

London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F.

Kidney Int. 1996 Aug;50(2):600-8.

44.

Influence of sex on arterial hemodynamics and blood pressure. Role of body height.

London GM, Guerin AP, Pannier B, Marchais SJ, Stimpel M.

Hypertension. 1995 Sep;26(3):514-9.

PMID:
7649591
45.
46.

[Pressure-independent improvement of aortic distensibility in hypertensive hemodialysed patients].

Pannier BM, Guérin AP, Marchais SJ, Cuche JL, Vicaut E, London GM.

Arch Mal Coeur Vaiss. 1994 Aug;87(8):1059-61. French.

PMID:
7755459
47.

Pathophysiology of left ventricular hypertrophy in dialysis patients.

London GM, Guerin AP, Marchais SJ.

Blood Purif. 1994;12(4-5):277-83. Review.

PMID:
7865187
48.

Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.

Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM.

Hypertension. 1993 Dec;22(6):876-83.

PMID:
8244520
49.

Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.

London GM, Marchais SJ, Guerin AP, Metivier F, Pannier B.

Kidney Int Suppl. 1993 Jun;41:S42-9. Review.

PMID:
8320946
50.

Arterial compliance and blood pressure.

Marchais SJ, Guerin AP, Pannier B, Delavaud G, London GM.

Drugs. 1993;46 Suppl 2:82-7. Review.

PMID:
7512488

Supplemental Content

Loading ...
Support Center